Health condition
Carcinoma of unknown primary
Carcinoma of unknown primary (CUP) means metastatic cancer is confirmed but its origin cannot be found; modern care balances a focused search with prompt treatment, using molecular profiling to find actionable targets and favourable subsets.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
CUP is a recognised diagnosis with its own treatment pathways - not a failure of investigation
-
A focused workup matters more than an endless one; treatment should not wait months
-
Favourable subsets (e.g. nodal disease patterns) are treated as their presumed origin, with better outcomes
-
Genomic profiling can reveal targetable mutations regardless of tissue of origin
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
Sometimes cancer is discovered already spread - in nodes, liver, bone - while scans, endoscopies and pathology fail to locate the original site, often because the primary is tiny or has regressed. The experience is uniquely disorienting: patients ask where it started and medicine answers honestly that it may never be known. Structured pathways exist precisely for this: immunohistochemistry narrows lineage, imaging is targeted rather than exhaustive, and dedicated CUP teams (a UK strength) coordinate the balance between searching and treating.
Diagnosis and treatment routes
Management has two tracks. Recognised favourable subsets - such as women with isolated axillary nodes treated as breast cancer, or squamous carcinoma in neck nodes treated as head and neck cancer - do considerably better with site-specific therapy. For the remainder, platinum-based chemotherapy remains the backbone while genomic and immune profiling increasingly redirects care toward targeted drugs, immunotherapy or trials based on the tumour’s biology rather than its birthplace. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant oncologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Carcinoma of unknown primary.
Quick, plain-English answers to what people ask us most.
-
What is carcinoma of unknown primary?
Carcinoma of unknown primary (CUP) is a diagnosis given when cancer is confirmed to have spread (metastasised) in the body, but despite thorough investigation, the original site where it started cannot be identified. It accounts for a small but significant proportion of cancer diagnoses. Treatment is guided by the tumor's characteristics under the microscope even without a confirmed origin.
-
Why can't the primary site always be found?
Sometimes the original tumor is too small to detect on scans, has been eliminated by the body's immune system after spreading, or is located somewhere not easily visualised on standard imaging. Despite extensive testing including scans, blood tests and biopsy analysis, in some cases the source genuinely cannot be pinpointed. This does not necessarily change how effectively the cancer can be treated.
-
What symptoms does it cause?
Symptoms depend on where the cancer has spread to — commonly lymph nodes, liver, bone, or lungs — and can include lumps, pain, weight loss, fatigue or organ-specific symptoms. There is often no symptom pointing to a particular starting organ, which is part of why the primary site remains unclear. Symptoms tend to reflect the metastatic sites rather than an original tumor.
-
Is carcinoma of unknown primary serious?
Yes, by definition it means the cancer has already spread, which generally makes it more serious than an early, localised cancer. However, outlook varies considerably depending on the tumor's biological behaviour and how well it responds to treatment, and some subtypes respond very well to targeted therapy. A specialist oncology team can identify more favourable subgroups within CUP.
-
How is it diagnosed and investigated?
Diagnosis involves biopsy of an accessible metastatic site, detailed pathology including immunohistochemistry and sometimes molecular/genomic testing, and imaging such as CT, PET or MRI to search for a primary site. This detailed workup helps classify the cancer's likely tissue of origin even without direct confirmation, which guides treatment choice.
-
How is carcinoma of unknown primary treated?
Treatment is tailored to the tumor's molecular and pathological features, and may include chemotherapy, targeted therapy, immunotherapy, or, in some cases, treatment as if a specific likely primary cancer type. Advances in molecular profiling increasingly allow more personalised treatment even without a confirmed primary site. A multidisciplinary oncology team guides these decisions.
-
When should I see a specialist?
If you have an unexplained lump, persistent pain, weight loss or other concerning symptoms, prompt assessment is important. NHS urgent cancer referral pathways aim to see patients quickly, though routine waits can extend beyond this; a private oncology consultation can typically be arranged within about 2 weeks to begin investigation.